Imperial College London

ProfessorHolgerAuner

Faculty of MedicineDepartment of Immunology and Inflammation

Visiting Professor
 
 
 
//

Contact

 

holger.auner04 Website

 
 
//

Assistant

 

Miss Mandy Sale +44 (0)20 3313 4017

 
//

Location

 

4N7ACommonwealth BuildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{Leleu:2021:10.1200/JCO.2021.39.15_suppl.8024,
author = {Leleu, X and Mateos, M-V and Jagannath, S and Delimpasi, S and Simonova, M and Spicka, I and Pour, L and Kriachok, I and Gavriatopoulou, M and Dimopoulos, MA and Pylypenko, H and Auner, HW and Reuben, B and Venner, CP and Garg, M and DeCastro, A and Shah, JJ and Grosicki, S and Richardson, PG},
doi = {10.1200/JCO.2021.39.15_suppl.8024},
publisher = {LIPPINCOTT WILLIAMS & WILKINS},
title = {Effects of refractory status to lenalidomide on safety and efficacy of selinexor, bortezomib, and dexamethasone (XVd) versus bortezomib and dexamethasone (Vd) in patients with previously treated multiple myeloma.},
url = {http://dx.doi.org/10.1200/JCO.2021.39.15_suppl.8024},
year = {2021}
}

RIS format (EndNote, RefMan)

TY  - CPAPER
AU - Leleu,X
AU - Mateos,M-V
AU - Jagannath,S
AU - Delimpasi,S
AU - Simonova,M
AU - Spicka,I
AU - Pour,L
AU - Kriachok,I
AU - Gavriatopoulou,M
AU - Dimopoulos,MA
AU - Pylypenko,H
AU - Auner,HW
AU - Reuben,B
AU - Venner,CP
AU - Garg,M
AU - DeCastro,A
AU - Shah,JJ
AU - Grosicki,S
AU - Richardson,PG
DO - 10.1200/JCO.2021.39.15_suppl.8024
PB - LIPPINCOTT WILLIAMS & WILKINS
PY - 2021///
SN - 0732-183X
TI - Effects of refractory status to lenalidomide on safety and efficacy of selinexor, bortezomib, and dexamethasone (XVd) versus bortezomib and dexamethasone (Vd) in patients with previously treated multiple myeloma.
UR - http://dx.doi.org/10.1200/JCO.2021.39.15_suppl.8024
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000708120604187&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
ER -